89 completed, 28 unknown, 14 not yet recruiting, 10 recruiting. 54 Phase 2, 49 Not applicable, 28 Phase 3, 27 Phase 1, 6 Phase 4.
Follow Androgenetic Alopecia: new trials by email Literature Review of Androgenetic Alopecia trials Research Report on Androgenetic Alopecia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia. Minoxidil oral solution, Placebo oral solution - Androgenetic Alopecia, Androgenetic Alopecia (AGA) | Phase 3 | Not yet recruiting | Eurofarma Laboratorios S.A. | 372 | 2027-01-31 | 2026-11-06 |
| Clinical Study of DA-002 and DA-005 as a Treatment for Hair Loss DA-005, Topical minoxidil 5%, DA-002 - Androgenetic Alopecia, Female Pattern Baldness | Phase 3 | Withdrawn | Applied Biology, Inc. | 2027-01-15 | 2026-11-02 | |
| A Study on the Efficacy and Safety of Microneedling for Male Androgenetic Alopecia Minoxidil 5 %, Microneedling - Androgenetic Alopecia | Not applicable | Not yet recruiting | Cheng Zhou | 190 | 2027-01-01 | 2026-08-11 |
| Comparing Standard Platelet-Rich Plasma and Light-Enhanced Platelet-Rich Plasma for Treating Hair Loss in Androgenetic Alopecia: A Randomized Controlled Trial Platelet-Rich Plasma (PRP) Injections, Red-light photobiomodulation with cooling, Blue-light photobiomodulation - Androgenetic Alopecia | Early Phase 1 | Not yet recruiting | Kimberly Meathrel | 30 | 2026-12-30 | 2026-07-31 |
| XVIE to Treat Androgenetic Alopecia (AGA) Decellularized allogeneic human amniotic fluid, Sodium chloride 0.9% injectable solution - Androgenetic Alopecia | Phase 1 / Phase 2 | Not yet recruiting | Restore Biologics Holdings, Inc. dba Xtressé | 30 | 2026-12-01 | 2026-08-12 |
| Efficacy of Botulinum Toxin A Versus Nanofat in the Treatment of Androgenetic Alopecia: A Comparative Clinical Trial Botulinum Toxin Type A, Autologous Nanofat Injection - Androgenetic Alopecia | Phase 2 / Phase 3 | Not yet recruiting | Sherief Ayman Hussein Shaamash | 40 | 2026-12-01 | 2026-10-07 |
| Study to Evaluate Xtressé Gummy Supplement in Women With Thinning Hair Xtressé Hair Growth Gummies, Placebo Comparator - Androgenetic Alopecia | Not applicable | Not yet recruiting | Restore Biologics Holdings, Inc. dba Xtressé | 30 | 2026-11-16 | 2026-11-12 |
| Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia PP405 0.05% Topical Gel, Vehicle Topical Gel - Androgenetic Alopecia | Phase 2 | Not yet recruiting | Pelage Pharmaceuticals, Inc. | 200 | 2026-11-01 | 2026-11-06 |
| Evidence-Based Integrated Protocol to Maximize Hair Follicle Survival in Follicular Unit Extraction (FUE) Integrated Evidence-Based FUE Protocol, Standard FUE Practice - Androgenetic Alopecia, Cicatricial Alopecia | Not applicable | Not yet recruiting | Assiut University | 30 | 2026-10-01 | 2026-09-30 |
| Phase 2/3 Efficacy and Safety of PP405 in Adult Males PP405 0.05% Topical Gel, Vehicle Topical Gel - Androgenetic Alopecia | Phase 2 / Phase 3 | Recruiting | Pelage Pharmaceuticals, Inc. | 600 | 2026-09-21 | 2026-10-28 |
| Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth DA-001, Placebo, Phenylephrine - Telogen Effluvium, Female Pattern Hair Loss | Phase 2 / Phase 3 | Not yet recruiting | Applied Biology, Inc. | 1120 | 2026-05-01 | 2026-04-13 |
| Harnessing Artificial Intelligence for Diagnosing Androgenetic Alopecia: A Training and Validation Study Androgenetic Alopecia | Not yet recruiting | Cairo University | 400 | 2026-04-25 | 2026-03-20 | |
| The Effect of Nanofat Injection on Androgenetic Alopecia Minoxidil 5 %, PRP injection, Nanofat injection - Androgenetic Alopecia, Androgenetic Alopecia (AGA) | Phase 4 | Not yet recruiting | Assiut University | 60 | 2026-04-01 | 2026-04-13 |
| Assessment of Dutasteride Topical Solution in Male Androgenetic Alopecia AD-303A, AD-3031 - Androgenetic Alopecia | Phase 1 / Phase 2 | Not yet recruiting | Moogene Medi Co., Ltd | 30 | 2026-04-01 | 2026-03-24 |
| JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil Topical Minoxidil 5% Solution, Scalp Punch Biopsy, Tissue JAK2 Protein Measurement by ELISA - Androgenetic Alopecia, Androgenic Alopecia | Not applicable | Recruiting | Kasr El Aini Hospital | 25 | 2026-02-01 | 2026-05-01 |
| Study of EPI-001 in Patients With Androgenetic Alopecia EPI-001, Placebo - Androgenetic Alopecia | Phase 1 / Phase 2 | Recruiting | Epibiotech | 42 | 2026-01-12 | 2026-06-01 |
| Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients Secretome, Platelet-Rich Plasma (PRP) Injections - Androgenetic Alopecia | Phase 1 / Phase 2 | Recruiting | PT. Prodia Stem Cell Indonesia | 40 | 2026-01-09 | 2026-02-24 |
| A Split-Scalp Study Evaluating the Efficacy and Safety of Fractional Laser Therapy With and Without Exosomes in the Treatment of Androgenetic Alopecia fraction laser - Androgenetic Alopecia | Not applicable | Recruiting | Chang Gung Memorial Hospital | 30 | 2025-12-26 | 2026-10-22 |
| Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study Plasma derived exosomes - Androgenetic Alopecia | Phase 1 / Phase 2 | Not yet recruiting | Ain Shams University | 15 | 2025-08-30 | 2025-08-08 |
| Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA) VDPHL01 QD, Placebo, VDPHL01 BID - Androgenetic Alopecia (AGA), Androgenetic Alopecia | Phase 3 | Active not recruiting | Veradermics, Inc. | 552 | 2025-07-25 | 2026-08-17 |
Showing 20 of 159. Sign in to see all of them.
Alopecia (159) · COVID-19 (3) · Hair Diseases (3) · Acne Vulgaris (1) · Alopecia Areata (1) · Anemia (1) · Bulbo-Spinal Atrophy, X-Linked (1) · Dermatitis, Seborrheic (1) · Hirsutism (1) · Hypotrichosis (1) · Insomnia, Fatal Familial (1) · Microtrauma, Physical (1) · Prostatic Hyperplasia (1) · Prostatic Neoplasms (1) · Severe Acute Respiratory Syndrome (1)
Pathological Conditions, Anatomical (159) · Pathological Conditions, Signs and Symptoms (159) · Skin and Connective Tissue Diseases (159) · Hypotrichosis (158) · Skin Diseases (158) · Hair Diseases (156) · Infections (4) · Coronaviridae Infections (3) · Coronavirus Infections (3) · Lung Diseases (3) · Nidovirales Infections (3) · Pneumonia (3) · Pneumonia, Viral (3) · RNA Virus Infections (3) · Respiratory Tract Diseases (3)
Minoxidil (27) · Finasteride (8) · Gels (4) · Percutaneous Collagen Induction (4) · Solutions (4) · Injections (3) · Sodium Chloride (3) · Bimatoprost (2) · Cetirizine (2) · Dutasteride (2) · Lasers, Solid-State (2) · Saline Solution (2) · AH 001 (1) · Botulinum Toxins, Type A (1) · Clascoterone (1)
Aderans Research Institute (11) · Applied Biology, Inc. (7) · Assiut University (4) · Lexington International, LLC (4) · Suzhou Kintor Pharmaceutical Inc, (4) · Veradermics, Inc. (4) · Biosplice Therapeutics, Inc. (3) · Cairo University (3) · Montefiore Medical Center (3) · Pelage Pharmaceuticals, Inc. (3) · Universitas Indonesia (3) · Addpharma Inc. (2) · Arbor Life Labs (2) · Chong Kun Dang Pharmaceutical (2) · Dr. Peter C. Friedman (2)
United States (63) · Egypt (13) · Germany (9) · South Korea (9) · China (7) · Spain (7) · Australia (6) · Indonesia (5) · India (4) · Pakistan (4) · Thailand (4) · Turkey (Türkiye) (4) · Brazil (3) · Canada (3) · Italy (3)
Andy Goren, MD (4) · Reid Waldman, M.D. (4) · Timothy Durso, M.D. (4) · Abe Marcadis, M.D. (3) · Kseniya Kobets, MD (3) · Yusuf Yazici, M.D. (3) · Christina Weng (2) · David Goldberg, M.D. (2) · Jerry Shapiro, MD (2) · Johannes Gassmueller, MD (2) · Michael Jarratt, M.D. (2) · Rajendarsingh Rajput, Dr. (2) · Sandeep Sattur, Dr. (2) · Adam Bodian, MD (1)
PMID 17196507, PMID 19366270, PMID 23960389, PMID 24078483, PMID 24559020, PMID 25124964, PMID 30886475, PMID 31823902, PMID 31984508, PMID 32237190, PMID 32283245, PMID 32301221, PMID 32333494, PMID 33112463, PMID 33346510, PMID 34235415, PMID 34350193, PMID 34541479, PMID 36571611, PMID 38833144, PMID 39386300, PMID 40021536, PMID 40736519, PMID 42018094